Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies

Saved in:
Bibliographic Details
Main Authors: Ulviye Acar Çevik, Ismail Celik, Şennur Görgülü, Zeynep Deniz Şahin İnan, Hayrani Eren Bostancı, Arzu Karayel, Yusuf Özkay, Zafer Asım Kaplancıklı
Format: Article
Language:English
Published: American Chemical Society 2025-02-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.4c08885
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850082712888541184
author Ulviye Acar Çevik
Ismail Celik
Şennur Görgülü
Zeynep Deniz Şahin İnan
Hayrani Eren Bostancı
Arzu Karayel
Yusuf Özkay
Zafer Asım Kaplancıklı
author_facet Ulviye Acar Çevik
Ismail Celik
Şennur Görgülü
Zeynep Deniz Şahin İnan
Hayrani Eren Bostancı
Arzu Karayel
Yusuf Özkay
Zafer Asım Kaplancıklı
author_sort Ulviye Acar Çevik
collection DOAJ
format Article
id doaj-art-0adfd107875e4c92b149d45c4c1f4e57
institution DOAJ
issn 2470-1343
language English
publishDate 2025-02-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj-art-0adfd107875e4c92b149d45c4c1f4e572025-08-20T02:44:28ZengAmerican Chemical SocietyACS Omega2470-13432025-02-011076801681310.1021/acsomega.4c08885Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico StudiesUlviye Acar Çevik0Ismail Celik1Şennur Görgülü2Zeynep Deniz Şahin İnan3Hayrani Eren Bostancı4Arzu Karayel5Yusuf Özkay6Zafer Asım Kaplancıklı7Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri, TurkeyMedicinal Plant, Drug and Scientific Research and Application Center (AUBIBAM), Anadolu University, Eskişehir, TurkeyDepartment of Histology and Embryology, Sivas Cumhuriyet University, Sivas, TurkeyDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, TurkeyDepartment of Physics, Faculty of Arts and Science, Hitit University, Çorum, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkeyhttps://doi.org/10.1021/acsomega.4c08885
spellingShingle Ulviye Acar Çevik
Ismail Celik
Şennur Görgülü
Zeynep Deniz Şahin İnan
Hayrani Eren Bostancı
Arzu Karayel
Yusuf Özkay
Zafer Asım Kaplancıklı
Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
ACS Omega
title Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
title_full Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
title_fullStr Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
title_full_unstemmed Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
title_short Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
title_sort novel benzimidazole oxadiazole derivatives as anticancer agents with vegfr2 inhibitory activity design synthesis in vitro anticancer evaluation and in silico studies
url https://doi.org/10.1021/acsomega.4c08885
work_keys_str_mv AT ulviyeacarcevik novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT ismailcelik novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT sennurgorgulu novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT zeynepdenizsahininan novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT hayranierenbostancı novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT arzukarayel novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT yusufozkay novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies
AT zaferasımkaplancıklı novelbenzimidazoleoxadiazolederivativesasanticanceragentswithvegfr2inhibitoryactivitydesignsynthesisinvitroanticancerevaluationandinsilicostudies